Arkolith/Insider Trading/RNA/Form 4

Flanagan W. Michael

Chief Scientific OfficerAvidity Biosciences, Inc. (RNA) · full profile →Form 4 · filed Sep 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$779K
Net Open-Market Flow
-$779K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2025Sell(S)20K$38.94$779K80K
Sep 11, 2025Option exercise(M)20K$14.22$284K100K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 11, 2025Option exercise(M)20K—$077K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599901-25-000184) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML